Apyx Medical Corporation
APYX
NGS
Sector: Healthcare
Industry: Medical Instruments & Supplies
4.66
USD
0.17
(3.79%)
Optionable: Yes Market Cap: 157 M 90-day average vol: 152,185
Previous close: 4.49 Open: 4.62 Bid: 5.34 Ask: 5.34
52 week range
3.01 17.50
Last updated: Tuesday 4th October 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Financials
APYX Income Statement
Annual
| Dec-12 | Dec-13 | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 28 M | 24 M | 28 M | 30 M | 9 M | 10 M | 17 M | 28 M | 28 M | 49 M |
| Cost of sales | 15 M | 14 M | 18 M | 16 M | 3 M | 3 M | 5 M | 8 M | 9 M | 14 M |
| Gross operating profit | 11 M | 9 M | 9 M | 13 M | 5 M | 7 M | 11 M | 19 M | 18 M | 34 M |
| Selling Gen & administrative expense | 9 M | 12 M | 13 M | 17 M | 15 M | 17 M | 22 M | 36 M | 34 M | 44 M |
| Research & development expense | 1 M | 1 M | 1 M | 2 M | 1 M | 2 M | 3 M | 4 M | 4 M | 4 M |
| Operating income | 1 M | -4 M | -6 M | -7 M | -11 M | -12 M | -14 M | -21 M | -20 M | -14 M |
| floaterest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| floaterest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other income net | 20000 | -842000 | -7 M | 2 M | 64000 | -1 M | -2 M | -351000 | 479000 | -373000 |
| Pre-tax Income (EBT) | 834000 | -6 M | -13 M | -5 M | -11 M | -14 M | -15 M | -20 M | -19 M | -15 M |
| Income taxes | 217000 | -2 M | 4 M | 25000 | 64000 | -156000 | -4 M | -130000 | -8 M | 380000 |
| Net income from total operations | 617000 | -4 M | -17 M | -5 M | -4 M | -5 M | 63 M | -20 M | -12 M | -15 M |
| Minority floaterest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total net income | 617000 | -4 M | -17 M | -5 M | -4 M | -5 M | 63 M | -20 M | -12 M | -15 M |
| Preferred dividends | N/A | 3 M | N/A | -14 M | N/A | N/A | N/A | N/A | N/A | N/A |
| Net income available for common | 617000 | -7 M | -17 M | -5 M | -12 M | -14 M | -11 M | -20 M | -12 M | -15 M |
| Depreciation | 857000 | 827000 | 876000 | 812000 | 734000 | 696000 | 669000 | 754000 | 887000 | 903000 |
| Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating income before depreciation (EBITDA) | 2 M | -5 M | -12 M | -4 M | -11 M | -13 M | -14 M | -19 M | -18 M | -14 M |
| Total Income available for floaterest expense (EBIT) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic EPS total | 0.04 | -0.25 | -1.03 | 0.34 | -0.14 | -0.16 | 1.89 | -0.58 | -0.35 | -0.44 |
| Diluted EPS total | 0.03 | -0.25 | -1.03 | 0.24 | -0.15 | -0.17 | 1.83 | -0.58 | -0.35 | -0.44 |
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONSGet started today